1[1]Chobanian AV. Vascular Effects of Systemic Hypertension[J]. Am J Cardiol,1992;69∶ 3- 7.
2[2]Weinberger MH. Calcium Antagonists for the treatment of systemic[J].AM J Cardiol,1992;69∶ 13- 16.
3[3]Schoenberger JA. Effects of Antihypertensive Agents on coronary[J]. Am J Cardiol,1992;69∶ 33- 39.
4[4]Hall VD. Hypertension in the Elderly with a special Focus on treatment with Angiotensin- converting Enzyme Inhibitors[J], Am J Cardiol,1992;69∶ 33- 42.
5[5]Schnaper HV. Angiotensin- converting Enzyme Inhibitors for systemic Hypertension in Young and Elderly patients[J], Am J Cardiol,1992;69∶ 54- 58.
6[6]Lees KR, Macfadven RJ.Reid JI. Tissue angintensin covetin enzyme in Hibition.Releveent To Clinical Practice[J]. Am J Hypertens.1990;3∶ 2665- 2725.
7[7]Johnston CL. Biochemists and Pharmacology of the rein angiotension system[J]. Durgs.1990∶ 39(suppl),P321- 315.
8[8]Melby Jc.anglotensin- Converting enzyine in Cardiovascular and adrent tissues and implicantions for successful blood menagement[J].Am J Cardiol,1992;68(10)∶ 2- 7.
9[9]Pzau VJ. Cardiac Venin- amgitonsin system molecular and functional aspects[J]. Am J Med.1998;84(3A)∶ 22- 27.
10[11]Fleet J Clinton S, Salomon R et al [J]. FASEBJ,1990;4∶ 1156.
